Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-10-27
1990-11-20
Stone, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530324, A61K 3702, C07K 710
Patent
active
049719521
ABSTRACT:
Inflammation, acute and/or chronic, is treated with a CIF (TGF-beta). The CIF may be administered locally or systemically, depending upon the indication, and does not require coadministration of activator or cofactor for efficacy.
REFERENCES:
patent: 4473551 (1984-09-01), Schinitsky
Shipley et al., (1985) Proc. Natl. Acad. Sci. USA 82:4147-4151.
Moses, (1985) Fed. Proc. 44(3), VIII abstract.
Kehrl et al., (1985) Clinical Research 33(2):610A.
Brinckerhoff, (1983) Arthritis and Rheumatism 26(11):1370-1379.
Tashjian et al., (1985) Proc. Natl. Acad. Sci. USA 82:4545-4538.
Roberts et al., (1985) Proc. Natl. Acad. Sci. USA 82:119-123.
Baserga, (1981) Handbook of Experimental Pharmacology 57:385-404.
Armstrong Rosa
Bentz Hanne
Ellingsworth Larry
Collagen Corporation
Stone Jacqueline
LandOfFree
Method of treating inflammation with cartilage inducing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating inflammation with cartilage inducing factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating inflammation with cartilage inducing factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-454379